Navigation Links
Dr. Fischer Said It Will Notify Pediatricians That Its Baby Eyelid Wipes Are Available At U.S. Pharmacies Contrary To What A Competitor Is Saying In Advertising About Its Wipes For Babies Being The 'First And Only' In The U.S. Market
Date:8/13/2012

NEW YORK, Aug. 13, 2012 /PRNewswire/ -- Dr. Fischer, the global pharmaceutical company based in Israel, said today it will send a letter to Pediatricians, Ophthalmologists and Pharmacists notifying them that its baby eyelid wipes have been available for some time at U.S. pharmacies contrary to what an eye-care competitor is saying in advertising about its baby eyelid & eyelash cleanser being the "first and only" such wipes in the U.S. market.

Not only does it plan to correct the record, but Dr. Fischer will take the opportunity also to point out that no one can miss its brand and world famous logo in pharmacies and that its eye-care wipes for babies individually are not only a superior product according to many pediatricians, but even much larger in size than the competitor's brand. 

"Dr. Fischer's baby eyelid wipes have been available at U.S. pharmacies since December 2008," said Tom Madden, CEO of  Dr. Fischer's public relations firm in the U.S., TransMedia Group (www.transmediagroup.com).   

"The Dr. Fischer eye-care for babies product started out on a small scale at private pharmacies and since June of this year distribution and sales have expanded significantly as more and more pediatricians and pharmacists started recommending Dr. Fischer Baby Eye-Care Wipes as well as other Dr. Fischer eye-care products," Madden said.

"All that Dr. Fischer is seeking to do is to make it known that there is not only one, but two eyelid wipes for children on the market and that Dr. Fischer's product has been available for some time," Madden said. 

"There's no reason why competitors can't compete amicably as long as that what they say about the market is accurate."

About Fischer Pharmaceuticals

Fischer Pharmaceuticals is a world leader in the development and manufacture of advanced health care preparations in the fields of dermatology, opthalmology and nutraceuticals.

The company's innovative R&D continually sets trends and norms in the industry, utilizing its' medical know-how with advanced pharmaceutical technology to offer consumers the best of both worlds; science and nature.

Media contact: Donna Balancia, 561-750-9800 x223 or donna@transmediagroup.com


'/>"/>
SOURCE Fischer Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
3. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
5. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
6. FUJIFILM Synapse® Mobility 3.0 Now Available In The U.S.
7. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
8. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Cytomedix, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Australien, 24. Februar 2017 ITL Limited, ... des Gesundheitsbereiches, ist erfreut, für das zum 31. ... entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine ... zum Wachstum" finden Sie hier . ... nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could ... in the United States may be taken over by technology in the next five ... steamrolls over colleagues is drawing to a close. Success will belong to those who ...
(Date:2/24/2017)... ... 24, 2017 , ... With millions of Americans and people ... we all are aware of our options and are empowered with strength and ... launch of its newest edition of "Vision and Hearing" in USA Today, that ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal ... Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, ... his attempts to overcome them. , Schanssema, initially unsure of the career path he ...
(Date:2/24/2017)... ... 2017 , ... The California State University Institute for Palliative Care ... interested in palliative care education and research. The Symposium, “Innovate. Investigate. Educate: Advancing ... Diego on Sept. 28 and 29, 2017, on the campus of California State University ...
Breaking Medicine News(10 mins):